INNOVATION
THAT GOES
BEYOND
HEALING

WHO WE ARE

Made in Africa, for Africa

Life after well

Qcil is a publicly listed pharmaceutical manufacturing company, established in Uganda by Ugandans in 2005. The Company is committed to advancing wellness and is the largest producer of WHO pre-qualified HIV/AIDS and Malaria treatments in the region.

At Qcil, we believe that health is not merely the absence of illness but the vibrant pursuit of life's possibilities. In Africa, we celebrate vitality and resilience – which is why, for us, it's about thriving, not surviving. Our belief makes us more than manufacturers of quality, affordable medications; we are enablers of “Life after well”.

about us image 1

OUR PRINCIPLES

vision

Vision

To become a centre of excellence in the manufacturing of quality, affordable medicines.

mission

Mission

To improve the quality of life by increasing access to effective, affordable medicines.

values

Values

quality
innovation
availability
affordability
trust

OUR JOURNEY

mobiledesktop

SUSTAINABILITY

Our sustainability strategy is anchored in our mission to provide affordable and effective medicines, while improving the quality of life in the communities in which we operate. The strategy focuses on two main objectives: reducing the environmental impact of our operations and contributing to the shared vision of our society.

orange line

CARBON
EMISSIONS

In respect of Scope 1 emissions, we are aspiring to achieve carbon neutrality by 2030.

space
green line

LAND
POLLUTION

We are focused on reducing waste generated by our operations that goes to landfill, and we aspire to achieve zero waste to landfill by 2025.

sustainability top
sustainability bottom
blue line

WATER
CONSUMPTION

We are committed to reducing our consumption of blue water and aim to achieve water neutrality by 2028.

space
pink line

WASTEWATER TREATMENT

Qcil is dedicated to meeting safe discharge targets established by the Antimicrobial Resistance Industry Alliance, ensuring responsible wastewater management.

QUALITY

quality 1
quality 2
quality 3

We are passionate about excellence and committed to providing the highest standard of products to our customers. Quality is embedded in every step of our operations, including procurement, manufacturing, packaging, testing, distribution, sales and safe product disposal. Our management systems ensure this excellence, guided by our quality policy and manual, which cover four key areas:

  1. Process performance and product quality monitoring.

  2. Corrective and preventive action.

  3. Change management.

  4. Management review of process performance and product quality.

Our focus is on enhancing our quality management systems to meet and exceed the expectations of regulatory authorities such as WHO, NDA, SAHPRA, ZAZIBONA, EAC and COMESA. We have digitised our quality management systems using applications like Trackwise. We recognise that adequate and timely investment in continuing to strengthen these systems will enhance stakeholder confidence and bolster compliance.

We have state-of-the-art manufacturing facilities that are cGMP-compliant, adhering to both national and international standards. Additionally, our quality control laboratories use the Laboratory Information Management System (LIMS), which significantly

enhances compliance in data management. Our facilities ensure quality through regular equipment upgrades, the adoption of technological advances, and the implementation of industry benchmarked practices.

Pharmacovigilance

Pharmacovigilance is an essential component of our quality management, enabling us to adopt adequate measures to identify and raise awareness about the adverse effects of our products. Our system is equipped to handle and process safety-related complaints efficiently. Through a structured customer complaint redressal system, drug safety complaints are directed to our pharmacovigilance team.

The pharmacovigilance team also undertakes measures to review current literature to understand evolving drug reactions. The redressal mechanism is supported by a dedicated phone line and mailbox, where safety-related complaints are received from consumers, patients, and healthcare professionals. We have an established Standard Operating Procedures for diligent follow-up with each reporter. As part of this follow-up, we inquire about the patient’s safety and obtain adequate information to assess the drug’s safety profile.

IMPACT ON SDGs

At Qcil, stewardship is integral to our Company strategy. We are committed to ensuring that every aspect of our business activities aligns with our sustainability agenda. Our dedication to Environmental, Social and Governance (ESG) principles is evident through the active support and leadership of our Board of Directors and Board-level committees. The Board has clearly defined our ESG priorities, set strategic direction, and is responsible for monitoring our ESG progress. We are also committed to advancing the Sustainable Development Goals (SDGs), a global framework for promoting a more responsible future. By aligning our ESG strategy with the SDGs, we ensure that our business activities contribute meaningfully to these global goals.

Specifically, our impact is reflected through eight SDGs that we have identified as material to the success of our business operations, namely:

good health wellbeing
quality eductaion
gender equality
clean water
decent work economic growth
industry innovation infrastructure
responsible consumption production
climate action

MANUFACTURING

man 1

Manufacturing

man 2

Packaging

man 3

Testing

man 4

Storage

man 5

Sale & Distribution

More than 350 employees

More than 1.4 billion tablets and hard gelatin capsule units/year

Additional warehouse capacity with more than 5000 pallets

FACTORY TOUR

Step inside our state-of-the-art facility and see how we’re revolutionising healthcare.

Watch now to witness innovation in action!

Qcil Factory Tour

REGULATORY APPROVALS

cgmp logo mau 2 min
glp logo
sadc logo 2
who logo
ecowas waho
eac logo
nda uganda
international council for harmonisation1

ISO Certified

We have implemented a robust Environmental, Health and Safety Management System (EHS MS) based on ISO standards, which operates as an integral part of our business activities and encompasses manufacturing, importation, sales and distribution of pharmaceutical products. In 2023, an annual surveillance and recertification audit was conducted by third-party auditors and no significant non-conformances were reported.

REGULATORY BODIES THAT HAVE
APPROVED OUR SITE/PRODUCTS

map

Our Leadership

Board of Directors

MR EMMANUEL KATONGOLE

MR EMMANUEL KATONGOLE

CO-FOUNDER & CHAIRMAN
View Biography
MR FREDERICK MUTEBI KITAKA

MR FREDERICK MUTEBI KITAKA

CO-FOUNDER & DIRECTOR
View Biography
MR GEORGE BAGUMA

MR GEORGE BAGUMA

CO-FOUNDER & DIRECTOR
View Biography
MR AJAY KUMAR PAL

MR AJAY KUMAR PAL

CHIEF EXECUTIVE OFFICER
View Biography
MRS BETH MANDEL

MRS BETH MANDEL

NON-EXECUTIVE DIRECTOR
View Biography
MR JOSEPH BALIDDAWA

MR JOSEPH BALIDDAWA

INDEPENDENT NON-EXECUTIVE
View Biography
DR PETER MUGYENYI

DR PETER MUGYENYI

INDEPENDENT NON-EXECUTIVE
View Biography
MR STEVENS MWANJE

MR STEVENS MWANJE

NON-EXECUTIVE DIRECTOR
View Biography
MR VUSI RASEROKA

MR VUSI RASEROKA

NON-EXECUTIVE DIRECTOR
View Biography

Management Team

MR AJAY KUMAR PAL

MR AJAY KUMAR PAL

CHIEF EXECUTIVE OFFICER
View Biography
MR FRED ANDREW KAKOOZA

MR FRED ANDREW KAKOOZA

CHIEF FINANCE OFFICER
View Biography
MR ATUL VADEPALI

MR ATUL VADEPALI

HEAD OF QUALITY CONTROL AND QUALITY ASSURANCE
View Biography
DR KIKUNDWA EMMA

DR KIKUNDWA EMMA

COMPANY PHARMACIST
View Biography
MR HARRISON KIGGUNDU

MR HARRISON KIGGUNDU

HEAD OF HUMAN RESOURCES
View Biography
MS PEACE NAMARA

MS PEACE NAMARA

ACTING COMPANY SECRETARY & HEAD OF LEGAL AFFAIRS
View Biography
MS SARAH MUSUMBA

MS SARAH MUSUMBA

HEAD OF ESG
View Biography
MR PANDA RAMAKANTA

MR PANDA RAMAKANTA

HEAD OF OPERATIONS
View Biography
MR MAHADEV MANDHARE

MR MAHADEV MANDHARE

HEAD OF SUPPLY CHAIN
View Biography
DR FRANCES PHILOMENA NAMATOVU

DR FRANCES PHILOMENA NAMATOVU

HEAD OF REGULATORY AFFAIRS AND PHARMACOVIGILANCE
View Biography
MR ROHIT DATAR

MR ROHIT DATAR

HEAD OF BUSINESS DEVELOPMENT AND PRIVATE MARKET
View Biography

AWARDS

award icon copy

WINNER

National Environment Sustainability Award for Exceptional Management of Active Chemicals - NEMA (2024)

award icon copy

Winner

Federation of Uganda Employer Award for Disability Inclusion (2023)

award icon copy

Winner

Outstanding Performance in Occupational Safety & Health Management (2023)

award icon copy

Winner

Best Practices in Learning and Development (2022 Survey)

award icon copy

Winner

Employer of the Year Award (2021/22 Survey)

award icon copy

Winner

Best Reward and Recognition Award - Prudential Best HR Practices (2021 Survey)

award icon copy

Winner

Financial Reporting Award - Fire Awards (2021)

award icon copy

Winner

Indian Business Forum Award - Contribution Towards the Pharmaceutical/Health Sector (2018)

award icon copy

Winner

Africa Award for Entrepreneurship - Transformational Business of the Year (2012)

award icon copy

Winner

Outstanding Achievement in Development of the Pharmaceutical Sector - Ministry of Health (2012)

award icon copy

Winner

Investor of the Year - Uganda Investment Authority (2007)